JP2016539148A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539148A5
JP2016539148A5 JP2016536528A JP2016536528A JP2016539148A5 JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5 JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5
Authority
JP
Japan
Prior art keywords
alkyl
group
optionally substituted
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536528A
Other languages
English (en)
Japanese (ja)
Other versions
JP6457523B2 (ja
JP2016539148A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075890 external-priority patent/WO2015082324A1/en
Publication of JP2016539148A publication Critical patent/JP2016539148A/ja
Publication of JP2016539148A5 publication Critical patent/JP2016539148A5/ja
Application granted granted Critical
Publication of JP6457523B2 publication Critical patent/JP6457523B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536528A 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン Expired - Fee Related JP6457523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195720 2013-12-04
EP13195720.1 2013-12-04
PCT/EP2014/075890 WO2015082324A1 (en) 2013-12-04 2014-11-28 Sulfoximine substituted quinazolines for pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2016539148A JP2016539148A (ja) 2016-12-15
JP2016539148A5 true JP2016539148A5 (enExample) 2017-11-30
JP6457523B2 JP6457523B2 (ja) 2019-01-23

Family

ID=49726564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536528A Expired - Fee Related JP6457523B2 (ja) 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン

Country Status (7)

Country Link
US (1) US10093660B2 (enExample)
EP (1) EP3077383B1 (enExample)
JP (1) JP6457523B2 (enExample)
AU (1) AU2014359456B2 (enExample)
CA (1) CA2929742C (enExample)
ES (1) ES2693520T3 (enExample)
WO (1) WO2015082324A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015169677A1 (en) * 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
AR117788A1 (es) * 2019-01-14 2021-08-25 Pi Industries Ltd Compuestos de fenilamidina 3-sustituida, preparación y uso
CN112812136B (zh) * 2019-11-15 2022-04-12 武汉光谷亚太医药研究院有限公司 新型2,3-二氢化茚衍生化合物、制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987192A (en) 1974-01-07 1976-10-19 The Upjohn Company Compositions and process of treatment
US5602118A (en) 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
CA2188772A1 (en) 1994-06-08 1995-12-14 Balreddy Kamireddy Cyclic sulfonamide herbicides
SE0102147D0 (sv) 2001-06-18 2001-06-18 Pharmacia Ab New methods
JP4518378B2 (ja) 2001-10-29 2010-08-04 ベーリンガー インゲルハイム インテルナツィオナール ゲゼルシャフト ミット ベシュレンクテル ハフツング エネルギー恒常性および細胞小器官代謝の調節に関与するMnkキナーゼ相同性タンパク質
CA2478050A1 (en) 2002-03-01 2003-09-12 Pfizer Inc. Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
GB0315587D0 (en) 2003-07-03 2003-08-13 Univ Dundee Anti-inflammatory assay and compounds
US7678920B2 (en) 2004-04-08 2010-03-16 Dow Agrosciences Llc Insecticidal N-substituted sulfoximines
EP1746099A1 (en) 2004-12-23 2007-01-24 DeveloGen Aktiengesellschaft Mnk1 or Mnk2 inhibitors
US20100143341A1 (en) * 2005-06-22 2010-06-10 Develogen Aktiengesellschaft Thienopyrimidines for pharmaceutical compositions
ZA200807715B (en) 2006-03-09 2009-11-25 Pharmacopeia Inc 9-Heteroarylpurine MNK2 inhibitors for treating metabolic disorders
EP2004656B1 (en) * 2006-04-07 2013-07-10 Boehringer Ingelheim International GmbH Thienopyrimidines having mnk1 /mnk2 inhibiting activity for pharmaceutical compositions
JP2009541268A (ja) 2006-06-22 2009-11-26 ビオヴィトルム・アクチボラゲット(プブリクト) Mnkキナーゼ阻害剤としてのピリジンおよびピラジン誘導体
DE102007024470A1 (de) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
WO2008141843A1 (en) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
WO2009092590A2 (en) 2008-01-25 2009-07-30 Syngenta Participations Ag Chemical compounds
EP2504010A4 (en) 2009-11-23 2013-04-17 Merck Sharp & Dohme Fused Bicyclic Pyrimidine Derivatives and Methods of Use Therefor
UY33241A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
UY33245A (es) 2010-02-26 2011-09-30 Boehringer Ingelheim Int Tienopirimidinas que contienen un grupo alquilo sustituido para composiciones farmacéuticas
AR088082A1 (es) 2011-10-13 2014-05-07 Lilly Co Eli Moduladores selectivos del receptor androgeno
ES2635262T3 (es) * 2012-11-09 2017-10-03 Evotec International Gmbh Quinazolinas sustituidas con sulfoximina para composiciones farmacéuticas
WO2014206922A1 (en) * 2013-06-28 2014-12-31 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines and their use as mnk1 and/or mnk2 kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2016515561A5 (enExample)
JP2013518107A5 (enExample)
JP2013542247A5 (enExample)
JP2016510326A5 (enExample)
JP2015508103A5 (enExample)
JP2014532647A5 (enExample)
JP2015511609A5 (enExample)
JP2014511891A5 (enExample)
JP2014518286A5 (enExample)
JP2016503797A5 (enExample)
RU2016141569A (ru) Комбинации
JP2017517538A5 (enExample)
HK1210771A1 (zh) 氮杂吲哚衍生物
JP2015509075A5 (enExample)
JP2017518360A5 (enExample)
JP2013518036A5 (enExample)
JP2014528464A5 (enExample)
JP2018525425A5 (enExample)
JP2015516419A5 (enExample)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
RU2015135824A (ru) Бициклические соединения пиримидона в качестве ингибиторов lp-pla2
JP2016539148A5 (enExample)
JP2016515550A5 (enExample)
JP2016516691A5 (enExample)
JP2021503451A5 (enExample)